Laser Photonics Secures $1.3 Million Order for Pharmaceutical Tablet Laser Drilling System

Reuters01-22
<a href="https://laohu8.com/S/LASE">Laser Photonics</a> Secures $1.3 Million Order for Pharmaceutical Tablet Laser Drilling System

Laser Photonics Corporation has announced the receipt of a $1.3 million order for its CMS Laser Pharmaceutical Tablet Laser Drilling System from a new international pharmaceutical customer. The custom TD-140 system is designed for single-sided drilling of up to 140,000 circular tablets per hour and incorporates advanced CO2 laser hardware, dual-vision inspection, and remote diagnostics. The system also includes software to assist customers in meeting FDA 21 CFR Part 11 requirements. This order highlights Laser Photonics Corporation's continued expansion in the pharmaceutical equipment sector.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laser Photonics Corporation published the original content used to generate this news brief on January 22, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment